1 / 5

Narcolepsy Market Trends 2019 Rising Opportunities, Size, Share, Segments and Revenue Forecast 2027

Access Complete Report at u2013 https://www.theinsightpartners.com/reports/narcolepsy-market/<br><br>Key factors driving the market are rising prevalence of sleep related disorders, emerging local pharmaceutical & biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, factors such as side effects and risks associated with narcolepsy medications and delayed diagnosis or misdiagnosis of narcolepsy are likely to restrain the market growth to a certain extent.<br>

dineshtbansode
Download Presentation

Narcolepsy Market Trends 2019 Rising Opportunities, Size, Share, Segments and Revenue Forecast 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Narcolepsy Market Publication Month: Feb 2019 | No. of Pages: 156 | Report Code: TIPRE00003326 | Category: Pharmaceuticals Narcolepsy Market to 2027 - Global Analysis and Forecasts by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography E-Mail : sales@theinsightpartners.com

  2. Narcolepsy Market Publication Month: Feb 2019 | No. of Pages: 156 | Report Code: TIPRE00003326 | Category: Pharmaceuticals Introduction: The relationship between public health and neurology was not been adequately explored until recent years. The burden of neurological disorders have increased significantly across the world. These disorders are estimated to affect over a billion population worldwide, according to the World Health Organization by 2016. Neurological disorders are commonly found among all the age groups, in all geographic populations. Similarly, sleep related neurological disorders that comprise a large group of diseases also affect a substantial population worldwide. These diseases majorly includes insomnia, sleep apnea, narcolepsyand others. Key factors driving the market are rising prevalence of sleep related disorders, emerging local pharmaceutical & biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, factors such as side effects and risks associated with narcolepsy medications and delayed diagnosis or misdiagnosis of narcolepsy are likely to restrain the market growth to a certain extent. E-Mail : sales@theinsightpartners.com

  3. Narcolepsy Market Publication Month: Feb 2019 | No. of Pages: 156 | Report Code: TIPRE00003326 | Category: Pharmaceuticals According to a new market research study titled 'Narcolepsy Market - Global Analysis and Forecasts by Type, Product and Distribution Channel, the global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The report highlights the trends prevalent in the global narcolepsy market and the factors driving the market along with those that act as deterrents to its growth. The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global Narcolepsy market based on products, application, and end users. It also provides market size and forecast till 2027 for overall Narcolepsy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region. E-Mail : sales@theinsightpartners.com

  4. Narcolepsy Market Publication Month: Feb 2019 | No. of Pages: 156 | Report Code: TIPRE00003326 | Category: Pharmaceuticals The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The Asia Pacific narcolepsy market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on sleep related neurological disorders. In addition, emergence of new local players with competitive drug portfolio are expected to fuel the market growth in Asia Pacific region. Get a PDF Sample copy of Narcolepsy Market: https://www.theinsightpartners.com/sample/TIPRE00003326/ E-Mail : sales@theinsightpartners.com

  5. Narcolepsy Market Publication Month: Feb 2019 | No. of Pages: 156 | Report Code: TIPRE00003326 | Category: Pharmaceuticals • The List of Companies • Bioprojet • Teva Pharmaceutical Industries Ltd. • Jazz Pharmaceuticals, Inc. • Graymark Healthcare, Inc. • Arena Pharmaceuticals, Inc. • Shire (Acquired by Takeda) • Ligand Pharmaceuticals, Inc. • Novartis AG, Mylan N.V. • Shionogi Inc. • Inquire more @ https://www.theinsightpartners.com/inquiry/TIPRE00003326/ E-Mail : sales@theinsightpartners.com

More Related